4Dong Hua Yang Ming Qing Zhang Jiang Du Chong Xu Oiao Ming Liang Ji Fang Mao Han Rong Qin Zi Rong Fan Department of Gastroenterology,Zhujiang Hospital,the First Military Medical University,Guangzhou 510282,China Laboratory of Molecular Biology,Zhujiang Hospital,the First Military Medical University,Guangzhou,China Departrnent of Biochemistry,the Second Military Medical University,Shanghai,China.Inhibitory effect of IGF-Ⅱ antisense RNA on malignant phenotype of hepatocellular carcinoma[J].World Journal of Gastroenterology,2000,6(2):266-267. 被引量：54
3Zhao-You Tang Liver Cancer Institute & Zhongshan Hospital of Fudan University Professor of Surgery Chairman.Liver Cancer Institute of Fudan University(previous Liver Cancer Institute of Shanghai Medical University)136 Yixueyuan Road,Zhongshan Hospital,Shanghai 200032,China..Hepatocellular Carcinoma-Cause,Treatment and Metastasis[J].World Journal of Gastroenterology,2001,7(4):445-454. 被引量：214
7[3]Sethi A,Shiffman ML.Approach to the management of patients with chronic hepatitis C who failed to achieve sustained virologic response.Infect Dis Clin North Am 2006; 20:115-135
8[4]Befeler AS,Di Bisceglie AM.Hepatocellular carcinoma:diagnosis and treatment.Gastroenterology 2002; 122:1609-1619
9[5]Saito Y,Saito H,Tada S,Nakamoto N,Horikawa H,Kurita S,Kitamura K,Ebinuma H,Ishii H,Hibi T.Effect of long-term interferon therapy for refractory chronic hepatitis c:preventive effect on hepatocarcinogenesis.Hepatogastroenterology 2005; 52:1491-1496
10[6]Shiratori Y,Imazeki F,Moriyama M,Yano M,Arakawa Y,Yokosuka O,Kuroki T,Nishiguchi S,Sata M,Yamada G,Fujiyama S,Yoshida H,Omata M.Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy.Ann Intern Med 2000; 132:517-524
4Du-Hu Liu Xue-Yong Zhang Dai-Ming Fan Yu-Xin Huang Jin-Shan Zhang Wei-Quan Huang Yuan-Qiang Zhang Qing-Sheng Huang Wen-Yu Ma Yu-Bo Chai Ming Jin Institute of Digestive Disease,Xijing Hospital,~2 Department of Gastroenterology,Tangdu Hospital,~3Department of Histology and Embryology,~4 Department of Microbiology,~5 Department of Biochemistry,Fourth Military Medical University,Xi’an 710033,Shaanxi Province,China.Expression of vascular endothelial growth factor and its role in oncogenesis of human gastric carcinoma[J].World Journal of Gastroenterology,2001,7(4):500-505. 被引量：37
5Zheng-Xu Wang~1 Gui-Fang Hu~1 Hong-Yang Wang~2 Meng-Chao Wu~2 1 Department of General Surgery,Chinese PEA General Hospital of Lanzhou Military Command,Lanzhou 730050,Gansu Province,China2 Eastern Hepatobilliary Surgical Hospital,Second Military Medical University,Shanghai 200438,China.Expression of liver cancer associated gene HCCA3[J].World Journal of Gastroenterology,2001,7(6):821-825. 被引量：9
3Yoshiji H, Yoshii J,Ikenaka Y. et al. Inhibition of renin--angiotensin system attenuates liver enzyme-altered preneoplastic lesions and fibrosis development in rats[J]. J Hepatol, 2002,37 : 22-30.
4Sakaida I, Hironaka K, Terai S, et al. Gadoliniumchloride reverses dimethylnit rosamine (DMN)2inducedrat liver fibrosis with increased mat rix metallo2proteinases (MMPs) of Kupffer cells[J]. Life Sei, 2003,72 (8) : 943-959.
5Iwai N, Inagami T. Identification of two subtypes in the rat type 1 angiotensin n receptor [J]. FEBS Lett, 1992, 298(2-3): 257.
6Zhu R, Yang L, Shen L, et al. ANG Ⅱ -AT1 receptor pathway is involved in the anti-fibrotic effect of beta-elemene [ J]. J Huazhong Univ Sci Technol Med Sci, 2009, 29(2) : 7-181.
7Bataller R, Sancho-Bru P, Gines P, et al. Liver fibrogenesis: a new role for the rennin-angiotensin system [ J ]. Antioxid Redox Signal, 2005, 7(9-10): 1346-1355.
8Wei Y, Clark SE, Morris EM, et al. Angiotensin Ⅱ -induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG (mRen2) 27(Ren2) rats [J]. J nepatol, 2008, 49(3): 417-428.
9Yoneda M, Hotta K, Noxaki, et al. Assoeiation between angiotensin Ⅱ typelreceptor polymorphisms and the occurrence of nonalcoholic fatty liver disease [J]. Liver Int 2009, 29(7) : 1078-1085.
10Ikura Y, Ohsawa M, Shirai N, et al. Expression of angiotensin Ⅱ type 1 receptor in human cirrhotic livers: its relation to fibfrosis and portal hypenension [J]. Hepatol Res, 2005, 32(2): 107-116.
